Michael T. Goldfarb, M.D.

Lecturer, Department of Dermatology

Selected Publications

1. Goldfarb MT, Woo TY, Rasmussen JE: Keratoderma hereditaria mutilans (Vohwinkel's Syndrome): A trial of isotretinoin. Pediatric Dermatology 1985; 2:216-218.
2. Ellis CN, Goldfarb MT, Roenigk HH Jr., Rosenbaum M, Wheeler S, Voorhees JJ: The effects of oral meclofenamate therapy in psoriasis. Journal of the Academy of Dermatology 1986; 14:49-52.
3. Goldfarb MT, Ellis CN, Voorhees JJ: Short-term and long-term considerations in the management of psoriasis with retinoids. Dermatologica 1987; 175:100-106.
4. Goldfarb MT, Ellis CN, Gupta AK, Tincoff T, Hamilton TA, Voorhees JJ: Acitretin improves psoriasis in a dose-dependent fashion. Journal of the American Academy of Dermatology 1988; 18:655-662.
5. Gupta AK, Goldfarb MT, Ellis CN, Park DS, Hamilton TA, Voorhees JJ: Side-effect profile of acitretin therapy in psoriasis. Journal of the American Academy of Dermatology 1989; 20:1088-1093
6. Goldfarb MT, Ellis CN, Weiss JS, Voorhees JJ: Topical tretinoin therapy: Its uses in photoaged skin. Journal of the American Academy of Dermatology 1989; 21:645-650.
7. Griffiths CEM, Goldfarb MT, Finkel LJ, Roulia V, Bonawitz M, Hamilton TA, Ellis CN, Voorhees JJ: Topical Tretinoin (retinoic acid) treatment of hyperpigmented lesions associated with photoaging in Chinese and Japanese patients: A vehicle-controlled trial. Journal of the American Academy of Dermatology 1994; 30:76-84.
8. Stern RA, Fitzgerald E, Ellis CN, Lowe N, Goldfarb MT, Baughman RD: The safety of etretinate as long-term therapy for psoriasis: Results of the Etretinate Follow-up Study. Journal of the American Academy of Dermatology 1995; 33:44-52